Global Systemic Antifungals Market Growth (Status and Outlook) 2023-2029
Fungal infections are generally divided into superficial infections and deep infections (also known as systemic infections). Superficial fungal infections are often caused by various species of fungi, while deep fungal infections mainly affect internal organs and deep tissues, with a low incidence but a mortality rate of up to 50%. Antifungals are drugs that have the ability to inhibit or kill pathogenic fungi and are used to treat fungal infectious diseases.
Translated with www.DeepL.com/Translator (free version)
LPI (LP Information)' newest research report, the “Systemic Antifungals Industry Forecast” looks at past sales and reviews total world Systemic Antifungals sales in 2022, providing a comprehensive analysis by region and market sector of projected Systemic Antifungals sales for 2023 through 2029. With Systemic Antifungals sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Systemic Antifungals industry.
This Insight Report provides a comprehensive analysis of the global Systemic Antifungals landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Systemic Antifungals portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Systemic Antifungals market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Systemic Antifungals and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Systemic Antifungals.
The global Systemic Antifungals market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Systemic Antifungals is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Systemic Antifungals is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Systemic Antifungals is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Systemic Antifungals players cover MSD, Pfizer, Astellas Pharma, Gilead Sciences, Merck, Bayer, Novartis, Liposome Company and Xian-janssen, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Systemic Antifungals market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Injections
Oral
Segmentation by application
Hospital
Clinic
Drugstores
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
MSD
Pfizer
Astellas Pharma
Gilead Sciences
Merck
Bayer
Novartis
Liposome Company
Xian-janssen
CR Pharma
Chiatai Tianqing
Haisco Pharmaceutical
Zhuhai Ebang Pharmaceutical
Livzon Group Livzon Pharmaceutical Factory
Honz Pharmaceutical
Medisan
Chengdu Brilliant Pharmaceutical
Please note: The report will take approximately 2 business days to prepare and deliver.
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
- 1.8 Market Estimation Caveats
- 2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Systemic Antifungals Market Size 2018-2029
- 2.1.2 Systemic Antifungals Market Size CAGR by Region 2018 VS 2022 VS 2029
- 2.2 Systemic Antifungals Segment by Type
- 2.2.1 Injections
- 2.2.2 Oral
- 2.3 Systemic Antifungals Market Size by Type
- 2.3.1 Systemic Antifungals Market Size CAGR by Type (2018 VS 2022 VS 2029)
- 2.3.2 Global Systemic Antifungals Market Size Market Share by Type (2018-2023)
- 2.4 Systemic Antifungals Segment by Application
- 2.4.1 Hospital
- 2.4.2 Clinic
- 2.4.3 Drugstores
- 2.4.4 Others
- 2.5 Systemic Antifungals Market Size by Application
- 2.5.1 Systemic Antifungals Market Size CAGR by Application (2018 VS 2022 VS 2029)
- 2.5.2 Global Systemic Antifungals Market Size Market Share by Application (2018-2023)
- 3 Systemic Antifungals Market Size by Player
- 3.1 Systemic Antifungals Market Size Market Share by Players
- 3.1.1 Global Systemic Antifungals Revenue by Players (2018-2023)
- 3.1.2 Global Systemic Antifungals Revenue Market Share by Players (2018-2023)
- 3.2 Global Systemic Antifungals Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
- 4 Systemic Antifungals by Regions
- 4.1 Systemic Antifungals Market Size by Regions (2018-2023)
- 4.2 Americas Systemic Antifungals Market Size Growth (2018-2023)
- 4.3 APAC Systemic Antifungals Market Size Growth (2018-2023)
- 4.4 Europe Systemic Antifungals Market Size Growth (2018-2023)
- 4.5 Middle East & Africa Systemic Antifungals Market Size Growth (2018-2023)
- 5 Americas
- 5.1 Americas Systemic Antifungals Market Size by Country (2018-2023)
- 5.2 Americas Systemic Antifungals Market Size by Type (2018-2023)
- 5.3 Americas Systemic Antifungals Market Size by Application (2018-2023)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
- 6 APAC
- 6.1 APAC Systemic Antifungals Market Size by Region (2018-2023)
- 6.2 APAC Systemic Antifungals Market Size by Type (2018-2023)
- 6.3 APAC Systemic Antifungals Market Size by Application (2018-2023)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 7 Europe
- 7.1 Europe Systemic Antifungals by Country (2018-2023)
- 7.2 Europe Systemic Antifungals Market Size by Type (2018-2023)
- 7.3 Europe Systemic Antifungals Market Size by Application (2018-2023)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 8 Middle East & Africa
- 8.1 Middle East & Africa Systemic Antifungals by Region (2018-2023)
- 8.2 Middle East & Africa Systemic Antifungals Market Size by Type (2018-2023)
- 8.3 Middle East & Africa Systemic Antifungals Market Size by Application (2018-2023)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
- 9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
- 10 Global Systemic Antifungals Market Forecast
- 10.1 Global Systemic Antifungals Forecast by Regions (2024-2029)
- 10.1.1 Global Systemic Antifungals Forecast by Regions (2024-2029)
- 10.1.2 Americas Systemic Antifungals Forecast
- 10.1.3 APAC Systemic Antifungals Forecast
- 10.1.4 Europe Systemic Antifungals Forecast
- 10.1.5 Middle East & Africa Systemic Antifungals Forecast
- 10.2 Americas Systemic Antifungals Forecast by Country (2024-2029)
- 10.2.1 United States Systemic Antifungals Market Forecast
- 10.2.2 Canada Systemic Antifungals Market Forecast
- 10.2.3 Mexico Systemic Antifungals Market Forecast
- 10.2.4 Brazil Systemic Antifungals Market Forecast
- 10.3 APAC Systemic Antifungals Forecast by Region (2024-2029)
- 10.3.1 China Systemic Antifungals Market Forecast
- 10.3.2 Japan Systemic Antifungals Market Forecast
- 10.3.3 Korea Systemic Antifungals Market Forecast
- 10.3.4 Southeast Asia Systemic Antifungals Market Forecast
- 10.3.5 India Systemic Antifungals Market Forecast
- 10.3.6 Australia Systemic Antifungals Market Forecast
- 10.4 Europe Systemic Antifungals Forecast by Country (2024-2029)
- 10.4.1 Germany Systemic Antifungals Market Forecast
- 10.4.2 France Systemic Antifungals Market Forecast
- 10.4.3 UK Systemic Antifungals Market Forecast
- 10.4.4 Italy Systemic Antifungals Market Forecast
- 10.4.5 Russia Systemic Antifungals Market Forecast
- 10.5 Middle East & Africa Systemic Antifungals Forecast by Region (2024-2029)
- 10.5.1 Egypt Systemic Antifungals Market Forecast
- 10.5.2 South Africa Systemic Antifungals Market Forecast
- 10.5.3 Israel Systemic Antifungals Market Forecast
- 10.5.4 Turkey Systemic Antifungals Market Forecast
- 10.5.5 GCC Countries Systemic Antifungals Market Forecast
- 10.6 Global Systemic Antifungals Forecast by Type (2024-2029)
- 10.7 Global Systemic Antifungals Forecast by Application (2024-2029)
- 11 Key Players Analysis
- 11.1 MSD
- 11.1.1 MSD Company Information
- 11.1.2 MSD Systemic Antifungals Product Offered
- 11.1.3 MSD Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023)
- 11.1.4 MSD Main Business Overview
- 11.1.5 MSD Latest Developments
- 11.2 Pfizer
- 11.2.1 Pfizer Company Information
- 11.2.2 Pfizer Systemic Antifungals Product Offered
- 11.2.3 Pfizer Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023)
- 11.2.4 Pfizer Main Business Overview
- 11.2.5 Pfizer Latest Developments
- 11.3 Astellas Pharma
- 11.3.1 Astellas Pharma Company Information
- 11.3.2 Astellas Pharma Systemic Antifungals Product Offered
- 11.3.3 Astellas Pharma Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023)
- 11.3.4 Astellas Pharma Main Business Overview
- 11.3.5 Astellas Pharma Latest Developments
- 11.4 Gilead Sciences
- 11.4.1 Gilead Sciences Company Information
- 11.4.2 Gilead Sciences Systemic Antifungals Product Offered
- 11.4.3 Gilead Sciences Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023)
- 11.4.4 Gilead Sciences Main Business Overview
- 11.4.5 Gilead Sciences Latest Developments
- 11.5 Merck
- 11.5.1 Merck Company Information
- 11.5.2 Merck Systemic Antifungals Product Offered
- 11.5.3 Merck Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023)
- 11.5.4 Merck Main Business Overview
- 11.5.5 Merck Latest Developments
- 11.6 Bayer
- 11.6.1 Bayer Company Information
- 11.6.2 Bayer Systemic Antifungals Product Offered
- 11.6.3 Bayer Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023)
- 11.6.4 Bayer Main Business Overview
- 11.6.5 Bayer Latest Developments
- 11.7 Novartis
- 11.7.1 Novartis Company Information
- 11.7.2 Novartis Systemic Antifungals Product Offered
- 11.7.3 Novartis Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023)
- 11.7.4 Novartis Main Business Overview
- 11.7.5 Novartis Latest Developments
- 11.8 Liposome Company
- 11.8.1 Liposome Company Company Information
- 11.8.2 Liposome Company Systemic Antifungals Product Offered
- 11.8.3 Liposome Company Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023)
- 11.8.4 Liposome Company Main Business Overview
- 11.8.5 Liposome Company Latest Developments
- 11.9 Xian-janssen
- 11.9.1 Xian-janssen Company Information
- 11.9.2 Xian-janssen Systemic Antifungals Product Offered
- 11.9.3 Xian-janssen Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023)
- 11.9.4 Xian-janssen Main Business Overview
- 11.9.5 Xian-janssen Latest Developments
- 11.10 CR Pharma
- 11.10.1 CR Pharma Company Information
- 11.10.2 CR Pharma Systemic Antifungals Product Offered
- 11.10.3 CR Pharma Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023)
- 11.10.4 CR Pharma Main Business Overview
- 11.10.5 CR Pharma Latest Developments
- 11.11 Chiatai Tianqing
- 11.11.1 Chiatai Tianqing Company Information
- 11.11.2 Chiatai Tianqing Systemic Antifungals Product Offered
- 11.11.3 Chiatai Tianqing Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023)
- 11.11.4 Chiatai Tianqing Main Business Overview
- 11.11.5 Chiatai Tianqing Latest Developments
- 11.12 Haisco Pharmaceutical
- 11.12.1 Haisco Pharmaceutical Company Information
- 11.12.2 Haisco Pharmaceutical Systemic Antifungals Product Offered
- 11.12.3 Haisco Pharmaceutical Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023)
- 11.12.4 Haisco Pharmaceutical Main Business Overview
- 11.12.5 Haisco Pharmaceutical Latest Developments
- 11.13 Zhuhai Ebang Pharmaceutical
- 11.13.1 Zhuhai Ebang Pharmaceutical Company Information
- 11.13.2 Zhuhai Ebang Pharmaceutical Systemic Antifungals Product Offered
- 11.13.3 Zhuhai Ebang Pharmaceutical Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023)
- 11.13.4 Zhuhai Ebang Pharmaceutical Main Business Overview
- 11.13.5 Zhuhai Ebang Pharmaceutical Latest Developments
- 11.14 Livzon Group Livzon Pharmaceutical Factory
- 11.14.1 Livzon Group Livzon Pharmaceutical Factory Company Information
- 11.14.2 Livzon Group Livzon Pharmaceutical Factory Systemic Antifungals Product Offered
- 11.14.3 Livzon Group Livzon Pharmaceutical Factory Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023)
- 11.14.4 Livzon Group Livzon Pharmaceutical Factory Main Business Overview
- 11.14.5 Livzon Group Livzon Pharmaceutical Factory Latest Developments
- 11.15 Honz Pharmaceutical
- 11.15.1 Honz Pharmaceutical Company Information
- 11.15.2 Honz Pharmaceutical Systemic Antifungals Product Offered
- 11.15.3 Honz Pharmaceutical Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023)
- 11.15.4 Honz Pharmaceutical Main Business Overview
- 11.15.5 Honz Pharmaceutical Latest Developments
- 11.16 Medisan
- 11.16.1 Medisan Company Information
- 11.16.2 Medisan Systemic Antifungals Product Offered
- 11.16.3 Medisan Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023)
- 11.16.4 Medisan Main Business Overview
- 11.16.5 Medisan Latest Developments
- 11.17 Chengdu Brilliant Pharmaceutical
- 11.17.1 Chengdu Brilliant Pharmaceutical Company Information
- 11.17.2 Chengdu Brilliant Pharmaceutical Systemic Antifungals Product Offered
- 11.17.3 Chengdu Brilliant Pharmaceutical Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023)
- 11.17.4 Chengdu Brilliant Pharmaceutical Main Business Overview
- 11.17.5 Chengdu Brilliant Pharmaceutical Latest Developments
- 12 Research Findings and Conclusion
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook